Furthermore, a novel protein (circMAPK14‐175aa), encoded by circMAPK14, exhibited tumour‐suppressive effects and competed with upstream kinase MKK6 to facilitate ubiquitin‐mediated degradation of FOXC1 and block CRC development. Here, MAP2K6 is linked to colorectal carcinoma.